Lipum AB Correlations

LIPUM Stock  SEK 16.20  0.40  2.41%   
The current 90-days correlation between Lipum AB and Annexin Pharmaceuticals AB is -0.12 (i.e., Good diversification). The correlation of Lipum AB is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
  
The ability to find closely correlated positions to Lipum AB could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Lipum AB when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Lipum AB - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Lipum AB to buy it.

Moving together with Lipum Stock

  0.67SHB-B Svenska HandelsbankenPairCorr

Moving against Lipum Stock

  0.88CAMX Camurus ABPairCorr
  0.83HNSA Hansa Biopharma ABPairCorr
  0.78VITR Vitrolife ABPairCorr
  0.64SEB-C Skandinaviska EnskildaPairCorr
  0.63NANOFS Nanoform Finland PlcPairCorr
  0.58SEB-A Skandinaviska EnskildaPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
CANTAALZCUR
ALZCURANNX
CANTAANNX
  
High negative correlations   
ALZCURACE
CANTAACE
CANTANXTCL
ALZCURNXTCL
ANNXACE
ANNXNXTCL

Risk-Adjusted Indicators

There is a big difference between Lipum Stock performing well and Lipum AB Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Lipum AB's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Lipum AB without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Transaction History Now

   

Transaction History

View history of all your transactions and understand their impact on performance
All  Next Launch Module

Lipum AB Corporate Management

Elected by the shareholders, the Lipum AB's board of directors comprises two types of representatives: Lipum AB inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Lipum. The board's role is to monitor Lipum AB's management team and ensure that shareholders' interests are well served. Lipum AB's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Lipum AB's outside directors are responsible for providing unbiased perspectives on the board's policies.
Pernilla AbrahamssonChief OfficerProfile
Associate LindquistCoFounder ResearchProfile
Pr HernellCoFounder DirectorProfile
Marina NorbergChief OfficerProfile
Einar PontenChief OfficerProfile